You are here

Article info

Article menu
Download PDFPDF
Commentary
Adult nursing
Alpha2 agonist dexmedetomidine may reduce duration of delirium in critically ill adults

Authors

  1. Correspondence to James Hill, Health Technology Assessment Group, University of Central Lancashire, Preston PR1 2HE, UK; jehill1{at}uclan.ac.uk
View Full Text

Citation

Hill J, Sange C, Clegg A
Alpha2 agonist dexmedetomidine may reduce duration of delirium in critically ill adults
Evidence-Based Nursing 2021;24:91.

Publication history

  • Accepted May 25, 2020
  • First published June 17, 2020.
Online issue publication 
June 21, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.